
Thrilled to have our recent work from the @marsonlab published in @ScienceMagazine science.org/doi/10.1126/scie…. This was the result of an awesome collaboration between myself and fellow Marson Lab postdoc, @R_Schmidt_ (1/12)

Postdoc in the @marsonlab @GladstoneInst/@UCSF. Parker Scholar @parkerici. Interested in genomics, CRISPR, cancer immunotherapy, and much more! 🇨🇦

Thrilled to have our recent work from the @marsonlab published in @ScienceMagazine science.org/doi/10.1126/scie…. This was the result of an awesome collaboration between myself and fellow Marson Lab postdoc, @R_Schmidt_ (1/12)

Excited to share that the Arce Lab is launching today at @arcinstitute ! We will explore the mechanisms controlling immune cell function using genomics and biochemistry in an effort to understand immune-mediated diseases. arcinstitute.org/labs/arcela…

Excited to share the latest from the @MarsonLab! An investigation of context-specific gene regulation in T cells, which led to dynamic mechanisms required to control T cell rest and activation. Published today in @Nature thanks to the work of many! nature.com/articles/s41586-0…

Excited to share a milestone in our forward genetics developments! Today in @Nature we report massive mutagenesis screening in T cells with base editors, increasing resolution from genes to nucleotides nature.com/articles/s41586-0… A @MarsonLab story with my dear friend @carlcward 1/10

I am very excited to share our paper on the interactions between #gdTcells and cancer cells, out today in @Nature! Using #CRISPR screens, we uncovered unexpected pathways in cancer cells regulating target molecules recognized by γδ T cells. @MarsonLab 1/2 nature.com/articles/s41586-0…

Happy to share the newest paper from our lab. Led by technician extraordinaire Aidan Tousley (soon to be an MD/PHD student!), this manuscript details our attempts to reimagine the structure of CARs to improve their specificity and efficacy. rdcu.be/c7avS

Thrilled to share the first Eyquem lab paper! Today we report in @CellCellPress evolving the AAV6 capsid to enable efficient engineering of murine T cells. An exciting collab with @asokanduke and led by the brilliants @WilliamNyberg and Jon Ark cell.com/cell/fulltext/S0092… 🧵1/11

I’m hiring a computational biologist at Genentech to analyze cutting-edge single-cell genomics and high-throughput screening data in an extremely collaborative environment focused on finding cures for disease. Please reach out to learn more. careers.gene.com/us/en/job/G…

I'm very excited to share our review article rdcu.be/cHLHy @NatRevImmunol where we discussed how IL-2 has been engineered since its discovery to improve its in vivo activity and T cell selectivity and drive therapeutic efficacy in the context of autoimmunity and cancer.

Lastly, on a personal note, special thanks to my wonderful and supportive wife @monika_mis 🤗

Thank you to the anonymous reviewers, @ScienceMagazine, and @ImmunoEditor for taking the time to provide important and constructive feedback.

Many thanks to all of co-authors for their valuable contributions, @madelinelaylay, @JakeFreimer, Raymund Bueno, Vinh Nguyen, Franzi Blaeschke, @yimmieg. Also, many thanks to all the members of the Marson Lab for so many helpful discussions!

We are super excited about the potential of these methods to discover new targets to incorporate into synthetic circuits for next generation T cell therapies! So many interesting facets of T cell biology to explore with this tech and we are very happy to share our protocols.

In summary, using paired genome-wide CRISPRa/i screens we comprehensively mapped the functional gene networks regulating IL-2 and IFN-g in human T cells. Arrayed and single-cell follow-up enabled deep investigation of hits, revealing how they affect stimulation-responsive states.

We found that that these CRISPRa perturbations not only enhanced or repressed overall activation, but steered T cells to different stimulation-responsive states, many of which were marked by the expression of different cytokine or other effector genes.

However, T cells are heterogenous in nature, so we asked how do these perturbations affect T cell states at the single-cell level? By pairing CRISPRa with single-cell RNA-seq (CRISPRa Perturb-seq) we were able to identify distinct cell states driven by ~70 genome-wide screen hits